NPPA expands price control to 23 additional drugs
The move will make drugs cheaper for patients. Manufacturers not complying with the ceiling price will have to deposit the overcharged amount with the government.
NEW DELHI : The drug price regulator—National Pharmaceutical Pricing Authority (NPPA)—has fixed the ceiling price of 18 formulations, and retail price of 23 new drugs by bringing them under price control. These drugs are largely used for treatment of rheumatoid arthritis, pain management, tuberculosis (TB), type 2 diabetes, respiratory illnesses and allergies.